IA Trial Radar

Discutamos y exploremos los ensayos clínicos con Centro Oncológico MD Anderson como patrocinador principal o colaborador.

Mostrando ensayos clínicos para Phase 1.

Puedo ayudarle a entender sus condiciones de salud, tratamientos o encontrar ensayos clínicos cercanos.
Nuestra herramienta de búsqueda solo admite inglés. Para búsquedas y discusiones en otros idiomas, use la IA Trial Radar o seleccione los filtros de condición médica y ubicación a continuación.
14 ensayos clínicos
 
Estado (Por defecto)
Aún No Recluta, Reclutando, Activo, No Reclutando
×
 
Condición médica
Phase 1
×
 
Título del estudio
Estado
Phase 1/2 Window Of Opportunity Study Of TROP2 CAR/IL-15 TGFBR2 KO NK Cells Delivered Intraperitoneally For The Management Of Gastric Cancer Metastatic To The Peritoneum NCT07509008
Aún no recluta
Phase1b/2 Trial Of AZA + APG1252 In Patients With High-Risk AML NCT07508982
Aún no recluta
Phase 1 Study Of SAR445877 In Combination With FOLFOX6 And Bevacizumab As First-Line Treatment For Microsatellite Stable Metastatic Colorectal Cancer NCT07500298
Aún no recluta
Phase1 Basket Trial Of CAR.70-Engineered IL15-Transduced With TGFBR2 Knock Out Cord Blood-Derived NK Cells For Relapsed/Refractory Lymphoid Malignancies NCT07444632
Aún no recluta
Dose Ranging, Toxicity Seeking, Phase 1 Trial of Oncolytic Adenoviral Therapy for Melanoma Intracranial and Extracranial Metastases NCT07444606
Aún no recluta
A Phase 1 Study Of FLAG Chemotherapy In Combination With Lisaftoclax And Pelcitoclax In Patients With Relapsed/Refractory T-Cell Acute Lymphoblastic Leukemia NCT07428486
Aún no recluta
Phase 1 Study Of Intrathecal Cellular Adoptive Immunotherapy Using Autologous CD8+ Antigen-Specific T Cells For Patients With Leptomeningeal Melanoma NCT07414979
Aún no recluta
Dual Administration Of Intraperitoneal And Intravenous TROP2-Directed CAR-NK With TGF-Beta Receptor 2 (TGFBR2) Knock Out (KO) Therapy For Colorectal Cancer-Related Peritoneal Carcinomatosis: A Phase 1/2 Trial ("Chip-CRC Trial") NCT07411599
Aún no recluta
Phase 1/1b Trial Of Olutasidenib And Ziftomenib For NPM1 And IDH1 Co-Mutated Acute Myeloid Leukemia NCT07411586
Aún no recluta
A Phase 1b Study of HC-7366, an Agonist of ISR With Immunotherapy in Kidney Cancer (SHARK) NCT07401875
Reclutando
Phase 1 Study of JV-394 Autologous Anti-CD94 CAR T for r/r CD94+ T/NK Cell Neoplasms NCT07382817
Reclutando
Phase 1 Study Of Izalontamab Brengitecan + Adagrasib In NSCLC - The IZA-A Trial NCT07382726
Aún no recluta
Phase 1b Trial of BMS-986504 in Combination With Olaparib in Patients With MTAP Loss NCT07382544
Reclutando
Phase 1/2 Study TROP2 CAREngineered Cord Blood-Derived NK Cells + Belzutifan In Pancreatic Cancer NCT07377526
Aún no recluta